Akkodis Named a Leader in ISG Provider Lens(TM) Digital Engineering Services 2026 Reports 
Sinch Mailgun Report: Companies are Leaving Email Performance on the Table 
Datavault AI Further Expands IP Portfolio with New Patent Issuance and Notices of Allowance 
GMG Appoints New Chief Production Growth Officer and Provides Update on Global Production Plans 
TMX Group Announces Agreement to Acquire Cboe Australia and Cboe Canada CORRECTION – Sorrento Therapeutics, Inc.
SAN DIEGO, Sept. 28, 2021 (GLOBE NEWSWIRE) — In a release issued on Tuesday, September 28th by Sorrento…
AB Science receives regulatory authorization to commence a second Phase 2 Covid-19 study
PRESS RELEASE AB SCIENCE RECEIVES REGULATORY AUTHORIZATION TO COMMENCE A SECOND PHASE 2 COVID STUDY…
Sorrento to Participate in the Benzinga Healthcare Small Cap Conference on September 30th
SAN DIEGO, Sept. 28, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”) is…
Researchers Discover Previously Unknown Role of BioAegis’ Therapeutic Gelsolin as Key Signaling Protein Vital for Regulating Immune Cell Inflammatory Response
This biological phenomenon, quorum sensing in macrophages, regulates the transition of cells from inflammatory to…
Accelus Announces Event Schedule to Facilitate Peer-to-Peer Surgeon Education During the 36th Annual North American Spine Society Meeting in Boston
PALM BEACH GARDENS, Fla., Sept. 28, 2021 (GLOBE NEWSWIRE) — Accelus, a privately held medical…
LIDDS patent covering the NanoZolid® production process granted in Russia and Australia
UPPSALA, SWEDEN – LIDDS AB (publ) announces today that its most recent patent family on…
AIM ImmunoTech Submits Pre-IND Application to the FDA for Phase 2 Clinical Studies of Ampligen as a Potential Early-Onset Therapeutic for COVID-19
AIM Has Reached Multiple Major Milestones Demonstrating Strong Progress in Developing its COVID-19 Portfolio OCALA,…
Scopus BioPharma’s Subsidiary Duet Therapeutics Set to Release Scientific Data During the 17th Annual Meeting of the Oligonucleotide Therapeutics Society
Duet releases video depicting mechanism of action for its proprietary CpG-STAT3 inhibitors to coincide with…
Todos Medical Announces October Conference Calendar
New York, NY, and Tel Aviv, ISRAEL, Sept. 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos…
Marrone Bio Advances Novel Herbicides
Three Biological-Based Herbicides Enter Late-Stage Development Phases; Potential $27 Billion Market DAVIS, Calif., Sept. 28,…
Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of REVTx 99, an Experimental Prophylactic Treatment for the Prevention of Respiratory Viral Infections
– Phase 2b study will investigate the efficacy of REVTx-99 on viral load and patient-reported…
Fortress Biotech to Participate in the Benzinga Healthcare Small Cap Conference
NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an…
Mustang Bio Announces MB-101 (IL13Rα2‐targeted CAR T cells) Scientific Presentations at Upcoming Virtual Conferences
Christine Brown, Ph.D., of City of Hope will present at the First Annual Conference on…
Impel NeuroPharma Announces Trudhesa™ (Dihydroergotamine Mesylate) Nasal Spray is Now Available for Prescription for the Acute Treatment of Migraine
Trudhesa is the First and Only Therapeutic to Use POD® Technology to Deliver Dihydroergotamine Mesylate…
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Redefining Standards, Refining Psychiatry
NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Tryp Therapeutics Inc. (CSE:…
Reneo Pharmaceuticals Hosting Key Opinion Leader Webinar on McArdle Disease and other Genetic Mitochondrial Myopathies
IRVINE, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical…
Outlook Therapeutics Reports New Positive 12-Month Safety Data from Pivotal Phase 3 NORSE TWO Trial
Full year data reinforce strong safety profile consistent with previous trials of ONS-5010 and with…
GENE Embarks on Breakthrough African American Collaboration for Breast Cancer as Part of Its Commitment to Ethnic Diversity
Study to focus on women of African American descent for expanded polygenic risk test MELBOURNE,…
Senti Bio Awarded Funding from National Cancer Institute (NCI) to Support Development of Logic Gated Allogeneic CAR-NK Cell Therapy SENTI-202 to Treat Acute Myeloid Leukemia
– Small Business Innovation Research (SBIR) contract to support development of pipeline program SENTI-202, a…
Agile Therapeutics Partners with Carli Lloyd, U.S. Women’s Soccer Star and Four-Time Olympian, to Bring Awareness to Women’s Health Topics
Partnership to focus on empowering women to take ownership of their health and healthcare options…